Clinical trial / 2008
Daily quercetin supplementation for 2 weeks dose-dependently increased plasma quercetin but did not alter antioxidant status, inflammation, or metabolism.
Thirty-five healthy volunteers were randomly assigned to supplement with 50, 100, or 150 mg/d of quercetin for 2 weeks. Compared with baseline, plasma quercetin concentrations significantly increased by 178% (50 mg/d), 359% (100 mg/d), and 570% (150 mg/d; P < 0.01 for all), with high interindividual variation (36-57%). Quercetin did not significantly affect serum uric acid, plasma alpha- and gamma-tocopherols, oxidized LDL, tumor necrosis factor-alpha, plasma antioxidative capacity, serum lipids, body composition, or resting energy expenditure.
- Study type
- Randomized controlled trial
- Who was studied
- 35 healthy volunteers
- What was measured
- Plasma quercetin concentrations, oxidant/antioxidant status, inflammation, and metabolism parameters
THE PAPER
Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans.
Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ. J Nutr, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.